Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

[1]  Oxford Centre for Evidence-based Medicine Levels of Evidence (January 2001) , 2014 .

[2]  N. Heaton,et al.  Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  K. Gurusamy,et al.  Which matters most: Number of tumors, size of the largest tumor, or total tumor volume? , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  C. Balabaud,et al.  Markers for microvascular invasion in hepatocellular carcinoma: Where do we stand? , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  M. Sherman,et al.  Does a patient qualify for liver transplantation after the down‐staging of hepatocellular carcinoma? , 2011, Liver transplantation.

[6]  M. Lesurtel,et al.  2010 International consensus conference on liver transplantation for hepatocellular carcinoma: Texts of experts , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  R. Busuttil,et al.  What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma? , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  A. Forner,et al.  What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation? , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  F. Durand,et al.  Is tumor biopsy necessary? , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  M. Abecassis,et al.  Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation? , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  A. Geier,et al.  Should we perform deceased donor liver transplantation after living donor liver transplantation has failed? , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  F. Villamil,et al.  Should we use living donor grafts for patients with hepatocellular carcinoma? ethical considerations , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  J. Trotter,et al.  Immunosuppression and hepatocellular carcinoma , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  J. Zucman‐Rossi,et al.  Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  T. Livraghi,et al.  Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[16]  R. Wiesner,et al.  Treatment of recurrent hepatocellular carcinoma after liver transplantation , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  V. Mazzaferro,et al.  Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: A review and consensus statement , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  J. Lee,et al.  Imaging diagnosis and staging of hepatocellular carcinoma , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  N. Girard,et al.  Is the treatment of hepatocellular carcinoma on the waiting list necessary? , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[20]  L. Mariani,et al.  Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence‐based analysis of 15 years of experience , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  J. Vauthey,et al.  Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[22]  H. Chung,et al.  Treatment of recurrent hepatocellular carcinoma after liver transplantation , 2011, Asia-Pacific journal of clinical oncology.

[23]  P. Clavien,et al.  Inhibition of mammalian target of rapamycin: two goals with one shot? , 2011, Journal of hepatology.

[24]  J. Llovet,et al.  New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers , 2010, Clinical Cancer Research.

[25]  R. Porte,et al.  Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[26]  Joong-Won Park,et al.  Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation , 2018, Journal of Korean medical science.

[27]  K. Shirabe,et al.  Improved Results of a Surgical Resection for the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation , 2010, Annals of Surgical Oncology.

[28]  D. Samuel,et al.  Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  日本肝癌研究会.  General rules for the clinical and pathological study of primary liver cancer , 2010 .

[30]  D. Harnois.  Sirolimus-Based Immunosuppression Is Associated with Increased Survival After Liver Transplantation for Hepatocellular Carcinoma , 2010 .

[31]  Y. Cheah,et al.  Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[32]  G. Klintmalm,et al.  Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[33]  S. Uemoto,et al.  Significance of Des‐Gamma‐Carboxy Prothrombin in Selection Criteria for Living Donor Liver Transplantation for Hepatocellular Carcinoma , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  M. Abecassis,et al.  A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[35]  A. Lauterio,et al.  Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. , 2009, Transplantation proceedings.

[36]  F. Pruvot,et al.  Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation. , 2009, Gastroenterologie clinique et biologique.

[37]  A. Horvath,et al.  Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. , 2009, Clinical chemistry.

[38]  J. Steenbeck,et al.  18F‐FDG‐Uptake of Hepatocellular Carcinoma on PET Predicts Microvascular Tumor Invasion in Liver Transplant Patients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[39]  A. M. Shapiro,et al.  Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database , 2009, Hepatology.

[40]  D. Harnois.  Reassessing Selection Criteria Prior to Liver Transplantation for Hepatocellular Carcinoma Utilizing the Scientific Registry of Transplant Recipients Database , 2009 .

[41]  S. Paggi,et al.  Sorafenib in Advanced Hepatocellular Carcinoma , 2008 .

[42]  L. Bolondi,et al.  Liver Transplantation for Hepatocellular Carcinoma: Results of Down‐Staging in Patients Initially Outside the Milan Selection Criteria , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[43]  Ryutaro Hirose,et al.  Excellent outcome following down‐staging of hepatocellular carcinoma prior to liver transplantation: An intention‐to‐treat analysis , 2008, Hepatology.

[44]  J. Trotter,et al.  Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[45]  C. Hsieh,et al.  Preliminary experience with gemcitabine and cisplatin adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[46]  J. Buckels,et al.  Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis , 2008, Gut.

[47]  Jun Chen,et al.  Liver Transplantation for Hepatocellular Carcinoma: Hangzhou Experiences , 2008, Transplantation.

[48]  Gordon H Guyatt,et al.  GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies , 2008, BMJ : British Medical Journal.

[49]  J. Marrero,et al.  A Novel Model Measuring the Harm of Transplanting Hepatocellular Carcinoma Exceeding Milan Criteria , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[50]  Johnny C. Hong,et al.  Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. , 2008, Archives of surgery.

[51]  J. Millis,et al.  Living donor liver transplantation: The ethics and the practice , 2007, Hepatology.

[52]  J. Roberts,et al.  Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF‐Expanded Criteria Based on Preoperative Imaging , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[53]  L. Meng,et al.  Adjuvant Adenovirus-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Administration Improves Outcome of Liver Transplantation in Patients with Advanced Hepatocellular Carcinoma , 2007, Clinical Cancer Research.

[54]  A. Lok,et al.  Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[55]  A. M. Shapiro,et al.  De Novo Sirolimus-Based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma: Long-Term Outcomes and Side Effects , 2007, Transplantation.

[56]  A. Gerbes,et al.  Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation , 2007, Clinical transplantation.

[57]  H. Petrowsky,et al.  Strategies for safer liver surgery and partial liver transplantation. , 2007, The New England journal of medicine.

[58]  Yingliang Ou,et al.  [Value of perioperative adjuvant therapy in liver transplantation for advanced hepatocellular carcinoma]. , 2007, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[59]  C. McLean,et al.  Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[60]  Y. Maehara,et al.  The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma—with special reference to the serum levels of des‐gamma‐carboxy prothrombin , 2007, Journal of surgical oncology.

[61]  Ping Zhu,et al.  A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation , 2007, Hepatology.

[62]  I. Ng,et al.  Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma , 2007, The British journal of surgery.

[63]  T. Lebret.  [What is the role of adjuvant therapy after nephrectomy?]. , 2007, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[64]  G. Klintmalm,et al.  Retransplantation for De Novo Hepatocellular Carcinoma in a Liver Allograft with Recurrent Hepatitis B Cirrhosis 14 Years After Primary Liver Transplantation , 2007, Digestive Diseases and Sciences.

[65]  I. McGilvray,et al.  Does Microvascular Invasion Affect Outcomes After Liver Transplantation for HCC? A Histopathological Analysis of 155 Consecutive Explants , 2007, Journal of Gastrointestinal Surgery.

[66]  T. Pfammatter,et al.  Transarterial Chemoembolization as a Bridge to Liver Transplantation for Hepatocellular Carcinoma: An Evidence‐Based Analysis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[67]  G. Klintmalm,et al.  Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation – a clinical and histological examination , 2006, Clinical transplantation.

[68]  Ann Harper,et al.  Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[69]  K. Höckerstedt,et al.  A prospective, randomized, multi‐centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma , 2006, Transplant international : official journal of the European Society for Organ Transplantation.

[70]  J. Roberts.  Tumor surveillance‐what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[71]  J. Joh,et al.  Liver transplantation for adult patients with hepatocellular carcinoma in Korea: Comparison between cadaveric donor and living donor liver transplantations , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[72]  M. Pompili,et al.  Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[73]  M. Abecassis,et al.  Outcomes of 385 Adult-to-Adult Living Donor Liver Transplant Recipients: A Report From the A2ALL Consortium , 2005, Annals of surgery.

[74]  M. Gnant,et al.  Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation? , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[75]  M. Makuuchi,et al.  Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients , 2005, Gut.

[76]  C. Broelsch,et al.  Liver resection for hepatocellular carcinoma in non‐cirrhotic liver without underlying viral hepatitis , 2005, The British journal of surgery.

[77]  D. Xiu,et al.  [Adjuvant chemotherapy after orthotopic liver transplantation for advanced hepatocellular carcinoma]. , 2005, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[78]  Xiao-feng Zhu,et al.  [Clinical study of adjuvant individualized chemotherapy for hepatocellular carcinoma after liver transplantation]. , 2004, Zhonghua wai ke za zhi [Chinese journal of surgery].

[79]  H. Isomoto,et al.  Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma , 2004, Journal of gastroenterology and hepatology.

[80]  P. Clavien,et al.  Critical evaluation of the different staging systems for hepatocellular carcinoma , 2004, The British journal of surgery.

[81]  G. Chau,et al.  Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. , 2004, Archives of surgery.

[82]  M. Makuuchi,et al.  The surgical approach to HCC: Our progress and results in Japan , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[83]  M. Kudo,et al.  Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) , 2003, Journal of Gastroenterology.

[84]  Charles M. Miller,et al.  Long-Term Results With Multimodal Adjuvant Therapy and Liver Transplantation for the Treatment of Hepatocellular Carcinomas Larger Than 5 Centimeters , 2002, Annals of surgery.

[85]  K. Leung,et al.  Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system , 2002, Cancer.

[86]  International Consensus Conference: , 2002, The breast journal.

[87]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[88]  A. Venook,et al.  Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.

[89]  L. Ellis,et al.  Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. , 2001, Archives of surgery.

[90]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[91]  S. Chevret,et al.  A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. , 1999, Journal of hepatology.

[92]  J. McCall,et al.  Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[93]  M. Lagman,et al.  Cyclosporine induces cancer progression by a cell-autonomous mechanism , 1999, Nature.

[94]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.

[95]  F. Izzo,et al.  A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients , 1998, Hepatology.

[96]  K. Olthoff,et al.  Adjuvant Chemotherapy Improves Survival After Liver Transplantation for Hepatocellular Carcinoma , 1995, Annals of surgery.

[97]  Johs Grundahl,et al.  The Danish consensus conference model , 1995 .

[98]  Simon Joss,et al.  Public participation in science : the role of consensus conferences in Europe , 1995 .

[99]  D. Dhumeaux,et al.  Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study , 1994, Cancer.

[100]  M. Kulkarni,et al.  Fibrolamellar Hepatocellular Carcinoma , 2010 .

[101]  A. Venook.  Liver transplantation for hepatocellular carcinoma Stone MJ, Klintmalm GBG, Polter D, Husberg BS, Mennel RG, Ramsay MAE, Flemens EE, Goldstein RM. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 1993; 104: 196–202 , 1993 .

[102]  G. Klintmalm,et al.  Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. , 1993, Gastroenterology.

[103]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[104]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[105]  H. Hasegawa,et al.  Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients , 1985, Cancer.